GLUD2 Antibodies

Santa Cruz Biotechnology features a diverse variety of GLUD2 monoclonal antibodies for advanced research in neuroscience and metabolic regulation. GLUD2 monoclonal antibodies are compatible with multiple applications, including western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). GLUD2, or glutamate dehydrogenase 2, plays a crucial role in the metabolism of glutamate, a key neurotransmitter in the central nervous system. GLUD2 is involved in the regulation of nitrogen metabolism and energy production, making it essential for maintaining cellular homeostasis. Understanding GLUD2 function is vital for elucidating its implications in neurological disorders and metabolic diseases. Researchers worldwide rely on GLUD2 monoclonal antibodies to investigate cellular pathways and molecular mechanisms. GLUD2 monoclonal antibodies enable detailed examination of glutamate metabolism and its impact on neural function. Current research utilizing GLUD2 monoclonal antibodies continues to reveal new insights about neurotransmitter regulation. Santa Cruz Biotechnology monoclonal antibodies support researchers in advancing scientific understanding of neurological and metabolic processes.